Innovative MedTech Inc. (IMTH)
USD 0.58
(34.88%)
USD 0.58
(34.88%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 6.13 Million USD | 6.55% |
| 2023 | 5.75 Million USD | -7.29% |
| 2022 | 6.21 Million USD | 17.19% |
| 2021 | 5.29 Million USD | 31.19% |
| 2020 | 4.03 Million USD | 6.89% |
| 2019 | 3.77 Million USD | 0.0% |
| 2014 | 3.03 Million USD | 13.72% |
| 2013 | 2.66 Million USD | 26.99% |
| 2012 | 2.1 Million USD | -15.36% |
| 2011 | 2.48 Million USD | -27.22% |
| 2010 | 3.4 Million USD | 53.74% |
| 2009 | 2.21 Million USD | 16.36% |
| 2008 | 1.9 Million USD | -0.83% |
| 2007 | 1.92 Million USD | 81.09% |
| 2006 | 1.06 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 6.02 Million USD | 4.59% |
| 2024 Q2 | 5.96 Million USD | -0.89% |
| 2024 Q3 | 6.03 Million USD | 1.12% |
| 2024 Q4 | 6.13 Million USD | 1.65% |
| 2023 FY | 5.75 Million USD | -7.29% |
| 2023 Q4 | 5.75 Million USD | -33.82% |
| 2023 Q1 | 6.99 Million USD | 12.68% |
| 2023 Q2 | 7.88 Million USD | 12.73% |
| 2023 Q3 | 8.69 Million USD | 10.28% |
| 2022 Q4 | 6.21 Million USD | 16.12% |
| 2022 FY | 6.21 Million USD | 17.19% |
| 2022 Q3 | 5.34 Million USD | 2.22% |
| 2022 Q2 | 5.23 Million USD | 1.12% |
| 2022 Q1 | 5.17 Million USD | -2.37% |
| 2021 Q3 | 5.39 Million USD | 0.0% |
| 2021 FY | 5.29 Million USD | 31.19% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | 5.29 Million USD | -1.72% |
| 2020 FY | 4.03 Million USD | 6.89% |
| 2019 FY | 3.77 Million USD | 0.0% |
| 2015 Q1 | 3.03 Million USD | 13.0% |
| 2014 Q1 | 2.66 Million USD | 2.06% |
| 2014 Q2 | 2.85 Million USD | 7.14% |
| 2014 Q3 | 2.96 Million USD | 3.93% |
| 2014 Q4 | 2.68 Million USD | -9.62% |
| 2014 FY | 3.03 Million USD | 13.72% |
| 2013 FY | 2.66 Million USD | 26.99% |
| 2013 Q2 | 2.29 Million USD | 9.4% |
| 2013 Q1 | 2.1 Million USD | -0.19% |
| 2013 Q4 | 2.61 Million USD | 0.62% |
| 2013 Q3 | 2.59 Million USD | 13.03% |
| 2012 Q1 | 2.48 Million USD | 2.22% |
| 2012 Q2 | 2.1 Million USD | -15.22% |
| 2012 Q3 | 1.99 Million USD | -5.1% |
| 2012 Q4 | 2.1 Million USD | 5.41% |
| 2012 FY | 2.1 Million USD | -15.36% |
| 2011 FY | 2.48 Million USD | -27.22% |
| 2011 Q2 | 3.62 Million USD | 6.21% |
| 2011 Q3 | 2.43 Million USD | -32.85% |
| 2011 Q4 | 2.42 Million USD | -0.17% |
| 2011 Q1 | 3.4 Million USD | 43.94% |
| 2010 FY | 3.4 Million USD | 53.74% |
| 2010 Q2 | 2.03 Million USD | -8.06% |
| 2010 Q1 | 2.21 Million USD | 5.28% |
| 2010 Q3 | 2.08 Million USD | 2.1% |
| 2010 Q4 | 2.36 Million USD | 13.78% |
| 2009 Q3 | 2.08 Million USD | 3.56% |
| 2009 FY | 2.21 Million USD | 16.36% |
| 2009 Q4 | 2.1 Million USD | 0.88% |
| 2009 Q1 | 1.9 Million USD | 11.74% |
| 2009 Q2 | 2.01 Million USD | 5.79% |
| 2008 Q2 | 2.06 Million USD | 7.55% |
| 2008 Q4 | 1.7 Million USD | 17.55% |
| 2008 FY | 1.9 Million USD | -0.83% |
| 2008 Q1 | 1.92 Million USD | 13.61% |
| 2008 Q3 | 1.45 Million USD | -29.8% |
| 2007 Q2 | 1.28 Million USD | 20.98% |
| 2007 Q3 | 1.39 Million USD | 8.95% |
| 2007 FY | 1.92 Million USD | 81.09% |
| 2007 Q4 | 1.69 Million USD | 20.93% |
| 2007 Q1 | 1.06 Million USD | 16.4% |
| 2006 Q3 | 631.93 Thousand USD | 20.96% |
| 2006 Q2 | 522.43 Thousand USD | 0.0% |
| 2006 Q4 | 911.52 Thousand USD | 44.24% |
| 2006 FY | 1.06 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -161.074% |
| Ansell Limited | 1.32 Billion USD | 99.539% |
| Ansell Limited | 1.33 Billion USD | 99.54% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 95.144% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -550.448% |
| Psykey, Inc. | 2.47 Million USD | -147.971% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.696% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.696% |
| Encision Inc. | 1.98 Million USD | -209.221% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -101.772% |
| LifePoint, Inc. | 2.45 Million USD | -149.976% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 39.742% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -80.437% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -101.783% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -690.238% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.375% |
| Sector 10, Inc. | 9.84 Million USD | 37.688% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.547% |
| SheerVision, Inc. | 1.43 Million USD | -328.59% |
| United Health Products, Inc. | 1.99 Million USD | -206.916% |
| Vasamed, Inc. | 1 Million USD | -510.25% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -61.431% |
| Yubo International Biotech Limited | 2.91 Million USD | -110.535% |